Clinical Trials on Healthy Volunteers (Diabetes Mellitus, Type 2)

Total 11870 results

Novo Nordisk A/S

Completed

A Study Comparing the Injection Site Pain Experience After the Injection of Semaglutide B and Semaglutide D With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and Obesity

Healthy Volunteers Diabetes Mellitus, Type 2 | Healthy Volunteers Overweight | Healthy Volunteers Obesity

Netherlands
Novo Nordisk A/S

Completed

A Study Comparing the Injection Site Pain Experience After the Injection of 2 Different Solutions of Semaglutide With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and Obesity

Healthy Volunteers Diabetes Mellitus, Type 2 | Healthy Volunteers Overweight | Healthy Volunteers Obesity

Netherlands
Turku University Hospital
University of Turku; University of Helsinki; Academy of Finland; European Foundation... and other collaborators

Unknown

The Effects of Short-time High-intensity Interval Training on Tissue Glucose and Fat Metabolism in Healthy Subjects and Patients With Type 2 Diabetes (HITPET)

Type 2 Diabetes Mellitus | Healthy Volunteers

Finland
AstraZeneca
Parexel

Completed

Phase 1 Bioequivalence Study of Dapagliflozin/Sitagliptin FDC vs Loose Combination of Single Components

Healthy Volunteers (Intended Indication: Type 2 Diabetes Mellitus)

Germany
Novo Nordisk A/S

Completed

A Clinical Trial Looking at the Comparability of 2 Different Forms of Semaglutide

Healthy Volunteers (Diabetes Mellitus, Type 2)

United Kingdom
Hoffmann-La Roche

Completed

A Study to Investigate in Healthy Volunteers (Part 1) and in Patients With Type 2 Diabetes Mellitus (Part 2) the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of RO6799477

Healthy Volunteer, Type 2 Diabetes

Netherlands
University Hospital, Montpellier

Completed

Polyphenols and Insulin Resistance (POLYOXRESIST)

Insulin Resistance | Healthy Volunteers | Type 2 Diabetes (T2D)

France
Novo Nordisk A/S

Completed

A Research Study of a New Medicine NNC0519-0130 in Healthy People, People With High Body Weight and People With Type 2 Diabetes.

Healthy Volunteers (Diabetes Mellitus, Type 2)

Germany, Denmark
Novo Nordisk A/S

Completed

A Study to Look at How Safe NNC0472-0147 is in Healthy People and in People With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Healthy Volunteers

Germany
Novo Nordisk A/S

Completed

A Research Study of How Oral Semaglutide Tablets Work in Healthy People Who Are Chinese

Diabetes Mellitus, Type 2 | Healthy Volunteers

China
Novo Nordisk A/S

Completed

A Research Study Looking at Similarity Between Once-weekly Semaglutide Versions for Different Injection Pens

Diabetes Mellitus, Type 2 | Healthy Volunteers

Germany
Eli Lilly and Company

Completed

A Study of Dulaglutide in Chinese Participants

Diabetes Mellitus, Type 2 | Healthy Volunteers

China
Centre Hospitalier Universitaire Dijon

Completed

Study of Immune Response in Obesity and Type 2 Diabetes (IMMUNOBEDIA)

Obesity | Type 2 Diabetes | Healthy Volunteers

France
Sirtris, a GSK Company
GlaxoSmithKline

Completed

A Clinical Study to Assess the Safety and Pharmacokinetics of SRT2104 in Normal Healthy Male Volunteers

Diabetes Mellitus, Type 2 | Healthy Volunteer

United Kingdom
Leiden University Medical Center
Andaluz Health Service

Completed

"POWER2DM Evaluation Campaign" (POWER2DMEC)

Diabetes Mellitus | Health Behavior | Self Efficacy | Type2 Diabetes Mellitus | Type1 Diabetes Mellitus

Netherlands, Spain
Klick Inc.
Mittal Global Clinical Trial Services

Completed

Type 2 Diabetes Glucose Biomarker Study With a Continuous Glucose Monitoring System

Healthy | Type 2 Diabetes Mellitus

Canada
Universiti Putra Malaysia

Completed

Effectiveness of Nutrition Education Intervention on Glycemic Control (HbA1c)

Type 2 Diabetes | Diet, Healthy | Health Knowledge, Attitudes, Practice

Iraq
University of Aberdeen
NHS Grampian

Unknown

Assessing the Effects of a Buckwheat Beverage on Postprandial Glucose Metabolism on Healthy and T2D Individuals (BUCKFOOD)

Healthy | Type2 Diabetes

United Kingdom
Shanghai General Hospital, Shanghai Jiao Tong University...

Not yet recruiting

AI Health Assistant and Type 2 Diabetes

Health Behavior | Type2 Diabetes Mellitus
Eli Lilly and Company

Completed

A Study of Tirzepatide (LY3298176) in Healthy Participants and Participants With Type 2 Diabetes (T2DM)

Healthy | Type 2 Diabetes Mellitus (T2DM)

United States, Singapore
Dongguan HEC Biopharmaceutical R&D Co., Ltd.

Completed

A Phase 1 Study of HEC88473 Injection in Healthy Subjects, Obese Subjects and T2DM Subjects

Obesity | Healthy Subjects | T2DM (Type 2 Diabetes Mellitus)

China
Medical University of Vienna

Unknown

Lipid and Glycogen Metabolism in Patients With Impaired Glucose Tolerance and Calcium Sensing Receptor Mutations (RISC_7T)

Type 2 Diabetes Mellitus | Type 1 Diabetes Mellitus | Healthy Volunteers | Prediabetes (Insulin Resistance, Impaired Glucose Tolerance) | Familiar Hypocalcuric Hypercalcemia

Austria
Novartis

Completed

Effect of LAF237 on Glucagon Secretion in Patients With Type 2 Diabetes and in Healthy Subjects

Healthy | Type-2 Diabetes

Germany
Novo Nordisk A/S

Completed

Comparison of Injection Site Pain Experience for Semaglutide and Dulaglutide sc

Obesity | Diabetes Mellitus, Type 2 | Overweight | Healthy Volunteers

Netherlands
Biolingus
Chinese University of Hong Kong

Recruiting

Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients With Type 2 Diabetes Mellitus

Diabete Type 2

Hong Kong
Cliniques universitaires Saint-Luc- Université...

Unknown

Impact of Changes in Muscle Secretome in the Remission of Type 2 Diabetes Mellitus Induced by Bariatric Surgery (MYDIASECRET)

Diabete Type 2

Belgium
Medical University of Graz

Completed

Prolonged Fasting on Glucose Metabolism and Hormonal Regulation in Healthy, Obese and Subjects With Type 2 Diabetes (PROLOG)

Healthy | Obesity | Type 2 Diabetes Mellitus | Type 1 Diabetes

Austria
Yating Liu

Completed

Effects of a Health Intervention on Hypoglycemic Coping : a Pilot Study

Hypoglycemia | Type 2 Diabetes Mellitus | Health Education

China
Diamontech AG
Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft...

Recruiting

Feasibility of Non-invasive Glucose Monitoring by Using Photothermal Deflectometry

Healthy | Diabetes Mellitus Type 2 | Diabetes Mellitus Type 1

Germany
Hanmi Pharmaceutical Company Limited

Completed

A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12460A (HM12460A)

Healthy | Type 2 Diabetes Mellitus | Type 1 Diabetes Mellitus

United States
Takeda

Completed

Alogliptin Tablets Special Drug Use Surveillance "Type 2 Diabetes Mellitus: Combination Therapy With Thiazolidinediones"

Type 2 Diabetes Melitus
Pfizer

Completed

Multiple Dose Study Of PF-05231023 In Adult Subjects Who Have Poor Lipid Control With And Without Type 2 Diabetes Mellitus

Diabetes Melliuts, Type 2

United States
Beni-Suef University

Unknown

Efficacy of ACE Inhibitors, MRAs and ACE Inhibitor/ MRA Combination

Diabetic Nephropathy Type 2 | Microalbuminuria Due to Type 2 Diabetes Mellitus

Egypt
Washington University School of Medicine

Completed

Fatty Acid Radiotracer Comparison Study in Heart Failure Patients

Heart Failure | Obesity | Type 2 Diabetes Mellitus | Health Normal Volunteer Subjects

United States
Hanmi Pharmaceutical Company Limited

Unknown

Multiple Ascending Dose Study of HM12470 in Type 1 and Type 2 Diabetes Mellitus

Type2 Diabetes Mellitus | Type1 Diabetes Mellitus

United States
Eli Lilly and Company

Completed

A Study of LY3537021 in Healthy Participants and Participants With Type 2 Diabetes Mellitus

Healthy | Type 2 Diabetes Mellitus

Singapore
Genmedica Therapeutics S.L.
Simbec Research

Terminated

Multiple Ascending Dose Study of GMC-252-L-Lys Salt in Healthy Subjects and Type 2 Diabetics

Healthy | Type 2 Diabetes Mellitus

United Kingdom
University of California, San Francisco

Completed

Effect of Genetic Variants in MATE1 and OCT3 on the Pharmacodynamics of Metformin in African Americans (#6113)

Healthy | Type 2 Diabetes Mellitus

United States
Eli Lilly and Company

Recruiting

A Study to Investigate the Safety and Tolerability of LY3938577 in Healthy Participants and Participants With Type 2 Diabetes Mellitus

Healthy | Type 2 Diabetes Mellitus

United States
Indiana University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Modulation of Human Myocardial Metabolism by GLP-1 Dose Response

Healthy | Type 2 Diabetes Mellitus

United States
Novo Nordisk A/S

Completed

A Research Study of How the Medicine NNC0480-0389 Taken With Semaglutide Works in the Body of Healthy Japanese Men

Healthy Volunteers Type 2 Diabetes

Japan
Novo Nordisk A/S

Completed

A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tablets

Type 2 Diabetes | Healthy Volunteers

Germany
Novo Nordisk A/S

Completed

A Research Study Looking at the Comparability of 2 Different Forms of Oral Semaglutide in Healthy People

Type 2 Diabetes | Healthy Volunteers

United States, Canada
Novo Nordisk A/S

Completed

A Research Study of a New Medicine NNC0113-6856 in Healthy Males

Type 2 Diabetes | Healthy Volunteers

Germany
Novo Nordisk A/S

Completed

A Clinical Trial Comparing Semaglutide in Healthy People Who Eat and Take the Medicine at Different Times

Healthy Volunteers Type 2 Diabetes

United Kingdom
Novo Nordisk A/S

Completed

A Study Investigating the Distribution and Metabolism of Three 14C-labeled Radioactive Study Compounds

Type 2 Diabetes | Healthy Volunteers

Netherlands
Novo Nordisk A/S

Completed

A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (C) Semaglutide Tablets

Type 2 Diabetes | Healthy Volunteers

Germany
Mathias Ried-Larsen

Completed

Exercise Volume and Beta-cell Function in T2D The DOSE-EX Randomized Trial (DOSE-EX)

Diabetes Mellitus, Type 2 | Type 2 Diabetes Mellitus | Type2 Diabetes | Type2 Diabetes Mellitus

Denmark
Eli Lilly and Company

Completed

A Single Dose Study of LY2605541 in Participants With Liver Impairment

Hepatic Insufficiency | Diabetes Mellitus, Type 2 | Healthy Volunteers

Germany, Hungary
Center for Diabetes, Copenhagen Municipality
Novo Nordisk A/S; University of Copenhagen; Innovation Fund Denmark; The Danish...

Completed

The Together on Diabetes Intervention - a Realist Evaluation

Type 2 Diabetes Mellitus | Health Behavior | Delivery of Health Care

Clinical Trials on Healthy Volunteers (Diabetes Mellitus, Type 2)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Italy

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations